Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8084586 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL12391382 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL7915160 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL7901399 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL9007163 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL7901402 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL1880843 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL1880842 | 1.00 | LMNA (0.48) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL1120158 | 0.98 | CA2 (0.49) | LMNACA2ALDH1A1KMT2ACA12 | |
| SCHEMBL1120157 | 0.98 | CA2 (0.49) | LMNACA2ALDH1A1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| EP-3919466-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | Yeda Research and Development Co. Ltd (IL) | 2021-12-08 | — | — | EP | disclosed |
| WO-2017137984-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-08-17 | — | — | WO | disclosed |
| US-20170237119-A1 | LI-ION ELECTROLYTE MEMBRANE FACILITATED BY A SELF-HEALING POLYMER MATRIX, AND ASSOCIATED BATTERY | UNIV COLORADO REGENTS (US) | 2017-08-17 | — | — | US | disclosed |
| US-20170237119-A1 | LI-ION ELECTROLYTE MEMBRANE FACILITATED BY A SELF-HEALING POLYMER MATRIX, AND ASSOCIATED BATTERY | UNIV COLORADO REGENTS (US) | 2017-08-17 | — | — | US | disclosed |
| US-9453099-B2 | Covalently cross-linked malleable polymers and methods of use | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-09-27 | — | — | US | disclosed |
| US-9453099-B2 | Covalently cross-linked malleable polymers and methods of use | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2016-09-27 | — | — | US | disclosed |
| US-9328069-B2 | Catalytic manufacturing method for imine having no substituent group on the nitrogen, and use for the imine produced | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-05-03 | — | — | US | disclosed |
| US-9328069-B2 | Catalytic manufacturing method for imine having no substituent group on the nitrogen, and use for the imine produced | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2016-05-03 | — | — | US | disclosed |
| US-20150344428-A1 | Catalytic Manufacturing Method for Imine Having No Substituent Group on the Nitrogen, and Use for the Imine Produced | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150344428-A1 | Catalytic Manufacturing Method for Imine Having No Substituent Group on the Nitrogen, and Use for the Imine Produced | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150259458-A1 | NOVEL COVALENTLY CROSS-LINKED MALLEABLE POLYMERS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2015-09-17 | — | — | US | disclosed |
| US-20150259458-A1 | NOVEL COVALENTLY CROSS-LINKED MALLEABLE POLYMERS AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2015-09-17 | — | — | US | disclosed |
| US-6200718-B1 | A POLYMERIZED TONER OF CORE-SHELL STRUCTURE, COMPRISING CORE PARTICLES COMPOSED OF COLORED POLYMER PARTICLES WHICH CONTAIN A COMPOUND HAVING >C=N+ STRUCTURE IN ITS MOLECULE AND A COLORANT AND A LAYER OF POLYMER COVERING CORE PARTICLES | NIPPON ZEON CO., LTD. (JP) | 2001-03-13 | — | — | US | disclosed |
| EP-0947888-A1 | POLYMER TONER AND METHOD OF PRODUCTION THEREOF | NIPPON ZEON CO., LTD. (JP) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | ADH1C, OTC, MLEC | LMNA 1261/4885CA2 131/4885ALDH1A1 1959/4885 |
| US-20150344428-A1 | Catalytic Manufacturing Method for Imine Having No Substituent Group on the Nitrogen, and Use for the Imine Produced | INMT, HNMT, NNMT | LMNA 2490/4885CA2 1488/4885ALDH1A1 580/4885 |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, ADH5 | LMNA 1251/4885CA2 169/4885ALDH1A1 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.